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What was known before: 1 
The inner segment ellipsoid band is correlated with visual function. EYS is an important and common cause of 2 
retinitis pigmentosa. 3 
 4 
 5 
What this study adds: 6 
The inner segment ellipsoid band of retinitis pigmentosa patients with EYS mutations shortened during the 5 7 
years of observation annually. The length of the inner segment ellipsoid band is a sensitive prognostic factor 8 
for the rate of ISe shortening in RP patients with EYS mutations. 9 
  10 
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To evaluate whether the length of the inner segment ellipsoid band (ISe) can be used as a 50 
prognostic factor for disease course in retinitis pigmentosa (RP) patients with EYS mutations 51 
by observation over a period of 5 years. 52 
METHODS: 53 
Twelve RP patients with EYS mutations were studied. The horizontal and vertical ISe length 54 
of the right eye was manually measured at five time-points annually, using spectral domain 55 
optical coherence tomography. A regression line through the five points from baseline to the 56 
final measurement was drawn and the ratio of the length (%) at each point to the baseline 57 
length was calculated; the slope was defined as the rate of ISe shortening (%/year). The 58 
correlation between rate of ISe shortening and age, visual acuity, and mean deviation (MD) 59 
value were evaluated. The intraclass correlation coefficient (ICC) for the measurements was 60 
calculated. 61 
RESULTS: 62 
The mean rate of ISe shortening was −4.65 ± 2.89% per year, and the decline was 63 
statistically significant. The rate of shortening was significantly negatively correlated with the 64 
baseline length (P = 0.046, r = 0.58), but not with the baseline age, visual acuity, and MD 65 
value. The ICC (2, 1) was 0.999. 66 
CONCLUSION: 67 
ISe of all RP patients with EYS mutations shortened during the 5 years of annual 68 
observation. The measurement of the length of ISe is simple and convenient method with 69 
high repeatability and the length is a sensitive prognostic factor for the rate of ISe shortening 70 




Retinitis pigmentosa (RP), a set of retinal diseases featuring degeneration of rod and cone 73 
photoreceptors, varies with regard to the onset of symptoms, inheritance mode, fundus 74 
appearance, and prognosis,1 possibly because of differences in causative gene mutations.2, 75 
3 Sixty RP causative gene mutations were found.4 76 
 EYS is an important and common cause of RP in the Japanese, Spanish, British, 77 
Chinese, Israelis, and Palestinians.5-9 Furthermore, a report has described that 78 
EYS-associated RP patients share a relatively uniform phenotype with near-normal central 79 
visual function up to their 20s.10 We have previously reported that severity of RP patients 80 
with EYS mutations was relatively moderate among RP patients with various mutations.11 81 
Thus, we encounter RP patients with EYS mutations at relatively high frequency in daily 82 
clinical consultation except detection for causative gene mutations, and RP patients with 83 
EYS mutations have representative feature in RP. It is significant to investigate RP patients 84 
with EYS mutations. 85 
 Although a change in the retinal structure of RP patients with the same genetic 86 
mutations over the medium-term (2 years) has been reported,12, 13 no study, to our 87 
knowledge, has investigated the changes over the longer term (5 years). Because the 88 
change of retinal structure is gradual, it is necessary to assess the change using a long-term 89 
follow-up data. Moreover, it is important to understand the change when explaining the 90 
disease course to patients in clinical practice. 91 
 It has been reported that evaluation of changes in the inner segment ellipsoid band 92 
(ISe) is useful for the assessment of retinal health, which is correlated with visual 93 
function.14-17 A previous 2-year study found that ISe decreases year-by-year in RP 94 
patients.18 95 
 From these perspectives, we conducted this study to evaluate whether the change 96 
of length of ISe over a long-term period in RP patients with EYS mutations can be used as a 97 
prognostic factor in predicting the disease course. 98 
 99 
Subjects and Methods 100 
This study was approved by the ethics committee of Kyoto University Graduate School of 101 
Medicine (Kyoto, Japan). All study protocols adhered to the tenets of the Declaration of 102 
Helsinki. The nature of the study and the possible risks and benefits of participation were 103 
explained to all study candidates. All subjects choosing to participate provided written 104 
informed consent. 105 
 106 
Subjects 107 
We performed gene analyses for 329 Japanese RP patients who visited the Department of 108 
Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, 109 
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Japan between January 2011 and December 2012 and agreed to provide peripheral blood 110 
samples.5 All patients underwent comprehensive ophthalmological examinations, including 111 
measurement of the best-corrected visual acuity (BCVA) using a decimal visual acuity chart 112 
(Landolt chart), indirect ophthalmoscopy, slit-lamp biomicroscopy, SD-OCT (Spectralis 113 
HRA+OCT, Heidelberg Engineering, Heidelberg, Germany); mean deviation (MD) value at 114 
baseline calculated using a Humphrey field analyzer (HFA; 10-2 SITA Standard Program; 115 
Carl Zeiss Meditec, Jena, Germany), and 30-Hz flicker electroretinography (ERG) were also 116 
performed. ERG results were recorded according to the International Society for Clinical 117 
Electrophysiology of Vision standard protocol recommended in 2008 using LS-C (Mayo Co., 118 
Nagoya, Japan) and Neuropack MEB-2204 systems (Nihon Kohden, Tokyo, Japan). All 119 
BCVA data were converted to the logarithm of the minimal angle of resolution (logMAR) for 120 
statistical analyses. Retinal specialists diagnosed RP using comprehensive 121 
ophthalmological examinations. In all the patients, EYS mutations were detected by 122 
next-generation sequencing. Inclusion criteria were: available SD-OCT images obtained 123 
over a period of 5 years, at five time points or more, on different days. Patients for whom ISe 124 
could not be detected on OCT images including dotted lines and those who had undergone 125 
intraocular surgery during the study period were excluded. Two investigators (MM and TH) 126 
determined whether the images were assessable. Those who had undergone intraocular 127 
surgery during the study period were also excluded. 128 
 129 
Inner Segment Ellipsoid Band Analysis 130 
The length of ISe on horizontal and vertical OCT B-scan crossing the fovea of the right eye 131 
was measured over 5 years using SD-OCT images of 30 × 30º scans (approximately 9 × 9 132 
mm), at five time points. The length of a healthy eye is approximately 9000 μm, because ISe 133 
is not cut within range of the SD-OCT images. Representative measurements were used for 134 
analysis, by averaging horizontal and vertical measurements. Measurements were 135 
performed obtained in a random order using the built-in measurement scale provided in the 136 
SD-OCT software (Figure 1). Information pertaining to the date of measurement was 137 
masked. If the OCT images were obtained at more than five time points, we selected five 138 
images obtained at almost equal time intervals. We plotted this data, with the baseline date 139 
up to the final measurement date on the x-axis and the percentage the length of ISe relative 140 
to that at baseline (%) on the y-axis. A regression line through the five data points from 141 
baseline to the final measurement date was then drawn; the slope was defined as the rate of 142 
ISe shortening (%/day). To improve comprehensibility, we converted the rate of ISe 143 
shortening (%/day) to the rate of ISe shortening (%/year) by multiplying by 365. To assess 144 
the repeatability of measurements, another investigator measured the length of ISe of five 145 




Statistical Analysis 148 
Data are presented as the mean ± standard deviation where applicable. All statistical 149 
analyses were performed using SPSS version 21 (IBM, New York, NJ, USA). Student's 150 
t-tests were used to compare different data sets. Correlations were analyzed using 151 
Pearson’s correlation coefficients. Linear regression analysis was performed to calculate the 152 
rate of ISe shortening. The intraclass correlation coefficient (ICC) value for the length of ISe 153 
measurements recorded by the two investigators (MM and TH) was calculated to determine 154 
the reliability of measurements. A P-value of < 0.05 was considered statistically significant.  155 
 156 
Results 157 
In total, 19 patients met the inclusion criteria for the study. Among these, ISe could not be 158 
detected in seven. Eventually, 12 patients were included in our analysis. In one patient, MD 159 
value at baseline was not available. Table 1 shows the patient characteristics. The 160 
observation period was 5.93 ± 0.74 years. The ICC (2, 1) value for the length of ISe 161 
measurements was 0.999. 162 
 Figure 2 shows the relationship between the length of ISe at each time point, relative 163 
to that at baseline, and the follow-up duration. The rate of ISe shortening was −4.65 ± 2.89% 164 
per year. There was a significant difference between the derived rate of ISe shortening value 165 
and 0 (P < 0.001), indicating a significant decrease in the length of ISe. When the cases 166 
were analyzed individually, there were significant differences between the rate of ISe 167 
shortening and 0 in all patients. When we separated the horizontal and vertical 168 
measurements to analyze, the rate of horizontal and vertical ISe shortening was −5.17 ± 169 
3.10 and −4.26 ± 2.98% per year, respectively. There was no differences in the rate between 170 
them (P = 0.70). 171 
 The rate of ISe shortening and the length of ISe at baseline were significantly 172 
correlated (P = 0.046, r = 0.58, Figure 3), i.e., the rate of ISe shortening value was high in 173 
patients with a small length of ISe value at baseline. However, there was no significant 174 
correlation between the rate of ISe shortening and age, log MAR visual acuity, and MD value 175 
at baseline (P = 0.84, 0.30, and 0.25, respectively, Figure 3). 176 
 The decrease in the MD value varied; the mean decrease was 3.09 ± 3.62 dB in the 177 
same 5-year period. Among 12 patients, six decreased by more than 2 dB and six 178 
decreased by less than 2 dB. The rate of ISe shortening was −5.17 ± 4.97 and −3.52 ± 179 
1.17% per year, respectively. There were no significant differences of the rate between in the 180 
two groups (P = 0.56). 181 
 182 
Discussion 183 
 This study evaluated whether the length of ISe, which is correlated with visual 184 
function, changes over a long-term period in RP patients with EYS mutations for the first 185 
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time. The length of ISe of the most RP patients with EYS mutations shortened during the 5 186 
years of annual observations and the rate of the length of ISe shortening was significantly 187 
higher in patients with a short length of ISe at baseline. 188 
 The length of ISe is a sensitive prognostic factor for the rate of ISe shortening in RP 189 
patients with EYS mutations. However, age, log MAR visual acuity, and MD value were not 190 
statistically significant prognostic factors in the present study, although a previous study has 191 
reported that the extent of visual fields constriction seemed to correlate better with age than 192 
with visual acuity.10 These findings help to explain the disease course to patients in clinical 193 
practice; i.e., disease progression of RP patients with EYS mutations with relatively longer 194 
ISe should be slow, while that of the patients with relatively shorter ISe should be rapid. 195 
However, we cannot predict the degree of disease progression from age, visual acuity, and 196 
visual field. To expand the application of this approach, further studies in degenerative retinal 197 
diseases with other mutations are needed. 198 
In this study, the rate of ISe shortening varied among patients with the same type of 199 
gene mutation, indicating that RP with the same gene mutation may not follow the same 200 
course in all patients. This finding is consistent with that in a previous study where patients 201 
with PRPH2 mutations exhibited different phenotypes.19 The previous studies showed a 202 
wide range of phenotypic expression from the same mutation: central areolar choroidal 203 
dystrophy, autosomal dominant RP, adult vitelliform macular dystrophy, and cone-rod 204 
dystrophy. 205 
Curcio et al showed that cone density decreased steeply with increasing eccentricity, 206 
while rod density increased with increasing eccentricity, and cone and rod density became 207 
the same at 0.5 mm from the fovea according to their published figure.20 Thus, an ISe 208 
shorter than 1000 μm was mainly constituted of cone cells. The results of the present study 209 
suggested that cone cells were more easily disordered than rod cells. There is a need for 210 
longitudinal study of the decrease in photoreceptors in RP patients using an adaptive optics 211 
scanning laser ophthalmoscope. 212 
In the present study, we selected the right eye in all cases to prevent selection bias. 213 
However, the symmetricity of progression of RP is also of interest. The ISe of left eye at 214 
baseline was 3180 ± 2348 μm, which was not significantly different from that of the right eye 215 
(3137 ± 2348 μm, P = 0.67). The ISe of the left eye at final measurement was 2558 ± 2325 216 
μm, which was also not significantly different from that of the right eye (2456 ± 2292 μm, P = 217 
0.20). Thus, progression of RP in patients with EYS mutations was symmetric in the present 218 
study. 219 
It is necessary to follow RP patients for at least 4 years to determine the true extent 220 
of changes, because RP is a disease with a long course. Indeed, because RP shows a 221 
definite but slow decline in visual function and degeneration of retinal structure, large clinical 222 
trials have set study periods for longer than 4 years, although their outcomes were different 223 
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from those of this study.21-23 224 
We converted the length of ISe to rate (%) in order to exclude the effect of the length 225 
of ISe, because this study included patients with various stages of the disease. For instance, 226 
although a change in the length of ISe from 8000μm to 7000μm indicates the same extent of 227 
progression as a reduction from 1500μm to 500μm, the implications are quite different. In 228 
fact, ISe at baseline was ranged from 481 to 7589 μm. 229 
This study had some limitations. First, measurement of the length of ISe was manual. 230 
Because ISe may not have a clear-cut edge, the measurement of ISe length can incur errors. 231 
We attempted to minimize the level of error as much as possible by two means. One was to 232 
make use of the slope of the regression line derived from OCT images obtained at five time 233 
points over 5 years; analysis of only two data points, i.e., baseline and approximately 5 years, 234 
would generate misleading results. The other was that the measurements of the length of 235 
ISe showed high repeatability; the ICC (2, 1) value was 0.999, indicating that almost the 236 
same length of ISe could be measured by any examiner. The measurement of the length of 237 
ISe is thus a relatively simple and facile, but accurate, method. Second, there were few 238 
young patients in this study. Although there was no significant correlation between the rate of 239 
ISe shortening and age at baseline, the rate of ISe shortening could not be determined in 240 
seven of the 19 patients (37%) in the EYS-RP group because of absence of assessable ISe, 241 
whereas it could be detected when they were younger. If the results of these patients were 242 
included in their youth, the results of this study may be different. Suto et al reported that ISe 243 
was absent in 40% RP patients with EYS mutations.10 The results of the present study (37%) 244 
were consistent with those of that previous report. Third, few patients had an intermediate 245 
length ISe at baseline. Among 12 RP patients, nine had ISe less than 4000 μm, two had ISe 246 
more than 6000 μm, and one had ISe ranged 4000−6000 μm. Further research of RP 247 
patients with middle ISe should be performed. 248 
 In conclusion, ISe of all RP patients with EYS mutations shortened during the 5 249 
years of observation annually. The measurement of the length of ISe is simple and 250 
convenient method with high repeatability and this length is a sensitive prognostic factor for 251 
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TITLES AND LEGENDS TO FIGURES 322 
 323 
Figure 1. Spectral domain optical coherence tomography images 324 
The length of the inner segment ellipsoid band crossing the fovea was measured in a 325 
random order using the measurement scale provided in the spectral-domain optical 326 
coherence software. Information pertaining to the date of measurement and type of gene 327 
was masked. 328 
 329 
Figure 2. Relationship between the percentage length of the inner segment ellipsoid band at 330 
the observation point relative to that at baseline and the follow-up duration. 331 
The mean ± standard deviation rate of the inner segment ellipsoid band shortening is −4.65 332 
± 2.89% per year. 333 


Table 1. Baseline characteristics of retinitis pigmentosa patients with EYS 
mutations included in this study 
SD: standard deviation, logMAR: logarithm of minimal angle resolution 
 
Characteristics Values 
Number of patients 12 
Patient age (years) 
 Mean ± SD 45.6 ± 8.6 
Range 34 to 63 
Patient sex, no. (%) 
 Male 3 (25) 
Female 9 (75) 
Visual acuity in the right eye, logMAR 
 Mean ± SD 0.040 ± 0.143 
Range −0.176 to 0.222 
Axial length in the right eye (mm)  
Mean ± SD 24.51 ± 0.99 
Range 22.7 to 25.9 
Mean deviation value as per Humphrey 
10-2 visual field analysis (dB)  (n=11)  
Mean ± SD −15.12 ± 7.16 
Range −25.36 to −1.11 
The length of the inner segment ellipsoid 
band measurement (μm)  
Mean ± SD 3137 ± 2350 
Range 481 to 7589 
Pseudophakia, no. (%) 1 (8) 
